AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ALOGLIPTIN 12.5 Mg ;
9 registrations across 1 African market— 9 active
Markets with ALOGLIPTIN 12.5 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Adwiagliptin 12.5mg Film Coated Tablets | 🇪🇬Egypt | Adwia | active | — |
| Gliptopack 12.5 mg Film Coated Tablets | 🇪🇬Egypt | Global Advanced pharmaceuticals "GAP" | active | — |
| Adwiagliptin 12.5mg Film Coated Tablets | 🇪🇬Egypt | Adwia | active | — |
| Gliptopack 12.5 mg Film Coated Tablets | 🇪🇬Egypt | Global Advanced pharmaceuticals "GAP" | active | — |
| Gliptawest Film Coated Tablets | 🇪🇬Egypt | Western Pharmaceuticals Industries | active | — |
| Aloglipt 12.5 mg Film Coated Tablets | 🇪🇬Egypt | International drug agency for pharmaceutical industry (IDI) | active | — |
| Prandaglim 12.5 mg Film Coated Tablets | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Gliptawest Film Coated Tablets | 🇪🇬Egypt | Western Pharmaceuticals Industries | active | — |
| Prandaglim 12.5 mg Film Coated Tablets | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
ALOGLIPTIN 12.5 Mg ; in Africa — Regulatory Overview
ALOGLIPTIN 12.5 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.